Bravecto Quantum is the first FDA-approved drug that treats and prevents flea and tick infestations on dogs for a duration of ...

The Food and Drug Administration has approved a first of its kind, once-yearly shot designed to protect dogs from fleas and ...

The U.S. Food and Drug Administration has approved Bravecto Quantum, a new shot that protects dogs six months or older ...

FDA approves Bravecto Quantum, the first injectable flea and tick treatment offering dogs up to 12 months of protection.

Rahway: Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., ...

Fluralaner for extended-release injectable suspension (Bravecto Quantum) is also indicated for treatment of lone star tick in ...

BRAVECTO QUANTUM (fluralaner for extended-release injectable suspension) for Dogs: The most commonly reported adverse reactions in a US field study included lethargy, decreased appetite, vomiting ...

Bravecto Quantum, a long-acting injectable flea and tick treatment from Merck Animal Health, received Food and Drug Administration approval for dogs at least six months old.

FDA approves Bravecto Quantum, the first injectable flea and tick treatment offering dogs up to 12 months of protection. 24/7 Live New York City New Jersey Long Island Northern Suburbs Connecticut.

Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the U.S. Food and Drug ...

The Brief. Bravecto Quantum, a breakthrough, long-acting flea and tick treatment and preventative for dogs, will be available soon. Made by Merck Animal Health, the once-yearly shot can protect ...